Literature DB >> 17688971

Standardization of needlestick injury and evaluation of a novel virus-inhibiting protective glove.

R Krikorian1, A Lozach-Perlant, A Ferrier-Rembert, P Hoerner, P Sonntag, D Garin, J-M Crance.   

Abstract

Rubber surgical gloves worn as a barrier to prevent contamination from body fluids offer relative protection against contamination through direct percutaneous injuries involving needles, scalpel blades or bone fragments. To determine the main experimental parameters influencing the volume of blood transmitted by a hollow-bore needle (worst case scenario) during an accidental puncture, we designed an automatic puncture apparatus. Herpes simplex type 1 virus (HSV1), a model for enveloped viruses, was used as a 'marker' in an in-vitro gelatine model. Of the experimental parameters studied, the most critical influences were found to be needle diameter and puncture depth, whereas puncture speed, puncture angle and glove-stretching feature appeared to be less influential. A single glove reduced the volume of blood transferred by 52% compared with no glove, but double gloving offered no additional protection against hollow-bore needle punctures. Using 'standardized' puncture conditions, the virus-inhibiting surgical glove G-VIR elicited an 81% reduction in the amount of HSV1 transmitted as compared with single or double latex glove systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688971     DOI: 10.1016/j.jhin.2007.05.008

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

1.  [Significance and prevention of post-operative wound complications].

Authors:  M Napp; D Gümbel; J Lange; P Hinz; G Daeschlein; A Ekkernkamp
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

2.  Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.

Authors:  Kai Dallmeier; Ursula Schultz; Michael Nassal
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.